TABLE 1

Pharmacokinetic parameters of edaravone, edaravone sulfate, and edaravone glucuronide in Bcrp knockout and wild-type mice

Edaravone was infused i.v. for 120 min. Each value was determined from the data shown in Figure 4 and the equations described under Materials and Methods. Each value represents the mean ± S.E. (n = 6).




Wild-type

Bcrp-/-
CLCRE (ml/min/kg) 10.9 ± 1.5 9.91 ± 2.76
CLtotal (ml/min/kg)
Edaravone 108 ± 3 111 ± 7
CLrenal, p (ml/min/kg)
Edaravone 0.963 ± 0.190 0.803 ± 0.229
Sulfate 10.5 ± 0.7 5.78 ± 0.51**
Glucuronide 25.2 ± 2.7 18.2 ± 1.8
CLrenal, k (ml/min/kg)
Sulfate 4.85 ± 0.33 3.62 ± 0.41*
Glucuronide 4.66 ± 0.41 3.66 ± 0.56
Ckidney (nmol/g kidney)
Edaravone 4.86 ± 0.59 4.29 ± 0.69
Sulfate 13.6 ± 1.2 13.8 ± 2.7
Glucuronide 13.3 ± 1.9 15.4 ± 2.5
Kp, kidney
Edaravone 2.85 ± 0.41 4.46 ± 1.92
Sulfate 2.23 ± 0.19 2.03 ± 0.22
Glucuronide 3.99 ± 0.55 4.04 ± 0.43
Urinary recovery (% dose)
Edaravone 0.871 ± 0.076 0.619 ± 0.120
Sulfate 28.9 ± 3.1 19.9 ± 2.1*
Glucuronide
37.0 ± 0.8
37.3 ± 3.7
  • * , P < 0.05, significantly different from wild-type mice using Student's t-test.

  • ** P < 0.01.